Goldman Sachs Group Inc Biote Corp. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 113,339 shares of BTMD stock, worth $439,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,339
Previous 113,339
-0.0%
Holding current value
$439,755
Previous $377,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BTMD
# of Institutions
89Shares Held
16.9MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$17.6 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$9.45 Million2.95% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$6.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.41MShares$5.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA701KShares$2.72 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $29.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...